EWS-WT1 Chimeric Protein in Desmoplastic Small Round Cell Tumor is a Potent Transactivator of FGFR4
暂无分享,去创建一个
M. Ladanyi | Tsuyoshi Saito | T. Nagao | H. Iwasaki | T. Yao | T. Motoi | Mayumi Yokotsuka
[1] R. Bentley,et al. FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma , 2012, Clinical Cancer Research.
[2] D. French,et al. Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models , 2012, PloS one.
[3] Helen X. Chen,et al. Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors , 2012, Clinical Cancer Research.
[4] M. Miyazaki,et al. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma , 2012, BMC Cancer.
[5] L. Borsu,et al. Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways , 2011, Clinical Cancer Research.
[6] M. Heinrich,et al. Gastrointestinal stromal tumours: origin and molecular oncology , 2011, Nature Reviews Cancer.
[7] A. Ullrich,et al. Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation , 2009, Clinical Cancer Research.
[8] M. Ladanyi,et al. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene , 2009, The Journal of pathology.
[9] K. Hotzel,et al. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. , 2008, Cancer research.
[10] W. Gerald,et al. Adenosine Transporter ENT4 Is a Direct Target of EWS/WT1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor , 2008, PloS one.
[11] William Pao,et al. Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond , 2008, Modern Pathology.
[12] H. Werner,et al. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene. , 2007, Cancer letters.
[13] M. Katoh,et al. Cross-talk of WNT and FGF signaling pathways at GSK3ß to regulate ß-catenin and SNAIL signaling cascades , 2006, Cancer biology & therapy.
[14] M. Ladanyi,et al. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. , 2006, Cancer research.
[15] Tsuyoshi Saito,et al. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma. , 2006, Human pathology.
[16] C. Robson,et al. Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer , 2005, British Journal of Cancer.
[17] N. Itoh,et al. Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.
[18] J. Inoue,et al. A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor. , 2003, The American journal of pathology.
[19] W. Gerald,et al. Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein. , 2003, Genes & development.
[20] W. Gerald,et al. Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. , 2002, Cancer cell.
[21] Y. Kaneko,et al. Establishment and Characterization of a Novel Human Desmoplastic Small Round Cell Tumor Cell Line, JN-DSRCT-1 , 2002, Laboratory Investigation.
[22] M. Jeffers,et al. Fibroblast growth factors in cancer: therapeutic possibilities , 2002, Expert opinion on therapeutic targets.
[23] G. Frantz,et al. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. , 2002, The American journal of pathology.
[24] H. Werner,et al. Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein , 2002, Oncogene.
[25] Gillian E. Wu,et al. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. , 2002, The Journal of clinical investigation.
[26] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[27] D. Haber,et al. Wilms tumor and the WT1 gene. , 2001, Experimental cell research.
[28] F. McCormick,et al. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.
[29] J. Pelletier,et al. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties , 1998, Oncogene.
[30] J. Pelletier,et al. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct , 1998, Oncogene.
[31] W. Gerald,et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour , 1997, Nature Genetics.
[32] H. Werner,et al. The IGF-I Receptor Gene Promoter Is a Molecular Target for the Ewing's Sarcoma-Wilms' Tumor 1 Fusion Protein* , 1996, The Journal of Biological Chemistry.
[33] W. Gerald,et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] S. Culine,et al. Desmoplastic small round cell tumors: results of a four‐drug chemotherapy regimen in five adult patients , 1996, Cancer.
[35] W. Gerald,et al. Desmoplastic Small Round-Cell Tumor: A Recently Recognized Tumor Type Associated with a Unique Gene Fusion , 1995 .
[36] W. Gerald,et al. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. Gerald,et al. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. , 1994, Cancer research.
[38] C. Denny,et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.
[39] J. Partanen,et al. Amplification of fgfr4 gene in human breast and gynecological cancers , 1993, International journal of cancer.
[40] E. Wills,et al. Intra‐Abdominal Desmoplastic Small Round Cell Tumor , 1993, Pathology.
[41] W. Gerald,et al. Intra‐abdominal Desmoplastic Small Round‐Cell Tumor: Report of 19 Cases of a Distinctive Type of High‐Grade Polyphenotypic Malignancy Affecting Young Individuals , 1991, The American journal of surgical pathology.